NSE filing, NSE: AGARWALEYE. Summary written from the filing by ALFA Finder's alert engine.
Dr. Agarwals Health Care Ltd: key numbers
- Share price
- ₹517.45
- Market cap
- ₹16,405 Cr
- Revenue (annual)
- ₹2,080 Cr
- Net profit (annual)
- ₹133.2 Cr
- P/E (TTM)
- 110.6×Sector 53.8×
- Promoter holding
- 32.33%-0.01% QoQ
- FII holding
- 49.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Agarwals Health Care Ltd
All →Dr. Agarwals Health Care Board Meeting Date
Dr. Agarwal's Health Care schedules a board meeting on November 5, 2026 to consider Q2 results. An earnings call follows at 6:30 PM IST that day.
Dr. Agarwals Health Care Merger & Restructuring Worth ₹711.2 Cr
Dr. Agarwals Health Care Limited has completed the merger of Dr. Agarwal's Eye Hospital Limited into itself for a total transaction value of ₹711.21 Crore.
- Value
- ₹711.2 Cr
Dr. Agarwals Health Care Employee Stock Options
Dr. Agarwal's Health Care Limited allotted 18,200 equity shares upon the exercise of vested ESOPs. The transaction is valued at approximately ₹0.24 Crore.
- Value
- ₹0.24 Cr
Dr. Agarwals Health Care Acquisition
The amalgamation scheme between Dr. Agarwal's Health Care and Dr. Agarwal's Eye Hospital is effective from November 01, 2026. The Record Date is November 18, 2026.
Dr. Agarwals Health Care Other Announcement
Dr. Agarwals Health Care Ltd has submitted its quarterly shareholding pattern statement for the quarter ended September 30, 2026, pursuant to SEBI Regulation 31(1)(b).
Dr. Agarwals Health Care Merger & Restructuring Worth ₹0.73 Cr
Dr. Agarwal's Health Care Ltd. completed the acquisition of its Nigeria-based step-down wholly owned subsidiary, previously announced on August 4, 2026, for ₹0.73 Crore.
- Value
- ₹0.73 Cr
Other board meeting outcome announcements
All →K Z Leasing & Finance Board Meeting Outcome
KZ Leasing & Finance's board adopted unaudited results for Q1 and H1 ending September 2026. No financial data is enclosed in this intimation.
Kasturi Metal Composite Board Meeting Outcome
Kasturi Metal Composite's board approved voluntarily publishing quarterly financial results from the quarter ending December 31, 2026. The mandatory SME filings remain half-yearly.
Tanvi Foods (India) Board Meeting Outcome
Tanvi Foods (India) Limited re-appointed Ms. Jonnada Vaghira Kumari as Non-Executive Independent Director for 60 months, effective 3 November 2026. This is a routine board-level director re-appointment.
Jyoti Structures Board Meeting Outcome
Jyoti Structures reconstituted its Nomination and Remuneration Committee and Risk Management Committee after its November 3, 2026 board meeting. The filing lists the revised members and chairpersons only.
Dhampure Specialty Sugars Board Meeting Outcome
Dhampure Speciality Sugars reconstituted its Audit, Nomination & Remuneration and Stakeholders' Relationship Committees effective 3 Nov 2026. No money or business event is involved.
Hardwyn India Board Meeting Outcome
Hardwyn India appointed M/s. Amit H.V. & Associates as the new Secretarial Auditor to fill a casual vacancy for the financial year 2025-2026.